Home

Überschrift Lehrer Fazit sq109 mechanism of action Gegen den Willen Beitrag Kaiser

SQ109 activity compared with ethambutol in the standard drug regimen... |  Download Scientific Diagram
SQ109 activity compared with ethambutol in the standard drug regimen... | Download Scientific Diagram

TB R&D Update: Tuberculosis drug, SQ109, targets multiple enzymes and could  treat other diseases while preventing resistance | Working Group for New TB  Drugs
TB R&D Update: Tuberculosis drug, SQ109, targets multiple enzymes and could treat other diseases while preventing resistance | Working Group for New TB Drugs

Insights on how the Mycobacterium tuberculosis heme uptake pathway can be  used as a drug target | Future Medicinal Chemistry
Insights on how the Mycobacterium tuberculosis heme uptake pathway can be used as a drug target | Future Medicinal Chemistry

New antituberculosis drugs, regimens, and adjunct therapies: needs,  advances, and future prospects - The Lancet Infectious Diseases
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects - The Lancet Infectious Diseases

SQ109, a new drug lead for Chagas disease. - Abstract - Europe PMC
SQ109, a new drug lead for Chagas disease. - Abstract - Europe PMC

Biomedicines | Free Full-Text | In Vivo Efficacy of SQ109 against  Leishmania donovani, Trypanosoma spp. and Toxoplasma gondii and In Vitro  Activity of SQ109 Metabolites | HTML
Biomedicines | Free Full-Text | In Vivo Efficacy of SQ109 against Leishmania donovani, Trypanosoma spp. and Toxoplasma gondii and In Vitro Activity of SQ109 Metabolites | HTML

New therapeutics in development and future directions | Current & Emerging  Diagnostics, Therapeutics & Vaccines for Tuberculosis
New therapeutics in development and future directions | Current & Emerging Diagnostics, Therapeutics & Vaccines for Tuberculosis

Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases |  Journal of Medicinal Chemistry
Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases | Journal of Medicinal Chemistry

Strategies towards the synthesis of anti-tuberculosis drugs - Organic &  Biomolecular Chemistry (RSC Publishing) DOI:10.1039/C9OB00817A
Strategies towards the synthesis of anti-tuberculosis drugs - Organic & Biomolecular Chemistry (RSC Publishing) DOI:10.1039/C9OB00817A

SQ109 mechanism of action The figure depicts stylized components of the...  | Download Scientific Diagram
SQ109 mechanism of action The figure depicts stylized components of the... | Download Scientific Diagram

APExBIO - SQ109|Antibiotic for treatment of pulmonary T|CAS# 502487-67-4
APExBIO - SQ109|Antibiotic for treatment of pulmonary T|CAS# 502487-67-4

SQ109 mechanism of action The figure depicts stylized components of the...  | Download Scientific Diagram
SQ109 mechanism of action The figure depicts stylized components of the... | Download Scientific Diagram

Discovery and development of SQ109: a new antitubercular drug with a novel  mechanism of action. | Semantic Scholar
Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action. | Semantic Scholar

SQ109 mechanism of action The figure depicts stylized components of the...  | Download Scientific Diagram
SQ109 mechanism of action The figure depicts stylized components of the... | Download Scientific Diagram

SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate  Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium  tuberculosis | Antimicrobial Agents and Chemotherapy
SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis | Antimicrobial Agents and Chemotherapy

Hydroxylation of antitubercular drug candidate, SQ109, by mycobacterial  cytochrome P450 | bioRxiv
Hydroxylation of antitubercular drug candidate, SQ109, by mycobacterial cytochrome P450 | bioRxiv

Discovery and development of SQ109: a new antitubercular drug with a novel  mechanism of action. - Abstract - Europe PMC
Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action. - Abstract - Europe PMC

New agents for the treatment of drug-resistant Mycobacterium tuberculosis -  ScienceDirect
New agents for the treatment of drug-resistant Mycobacterium tuberculosis - ScienceDirect

SQ109 mechanism of action The figure depicts stylized components of the...  | Download Scientific Diagram
SQ109 mechanism of action The figure depicts stylized components of the... | Download Scientific Diagram

SQ109 | Infectex
SQ109 | Infectex

Structure–activity relationship of SQ-109. | Download Scientific Diagram
Structure–activity relationship of SQ-109. | Download Scientific Diagram

Global tuberculosis drug development pipeline: the need and the reality -  The Lancet
Global tuberculosis drug development pipeline: the need and the reality - The Lancet

Hydroxylation of antitubercular drug candidate, SQ109, by mycobacterial  cytochrome P450 | bioRxiv
Hydroxylation of antitubercular drug candidate, SQ109, by mycobacterial cytochrome P450 | bioRxiv

Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based  antitubercular drug. - Abstract - Europe PMC
Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug. - Abstract - Europe PMC

Applied Sciences | Free Full-Text | Mycobacterial Cell Wall: A Source of  Successful Targets for Old and New Drugs | HTML
Applied Sciences | Free Full-Text | Mycobacterial Cell Wall: A Source of Successful Targets for Old and New Drugs | HTML

SQ109 = 98 HPLC 502487-67-4
SQ109 = 98 HPLC 502487-67-4

Direct Inhibition of MmpL3 by Novel Antitubercular Compounds | ACS  Infectious Diseases
Direct Inhibition of MmpL3 by Novel Antitubercular Compounds | ACS Infectious Diseases

IJMS | Free Full-Text | Hydroxylation of Antitubercular Drug Candidate,  SQ109, by Mycobacterial Cytochrome P450 | HTML
IJMS | Free Full-Text | Hydroxylation of Antitubercular Drug Candidate, SQ109, by Mycobacterial Cytochrome P450 | HTML